Diamines & Chemicals Limited has submitted its fund utilization disclosure to stock exchanges for the quarter ended December 31, 2025, in compliance with SEBI Regulation 32(1). The filing provides details on the deployment of funds raised through a preferential issue of convertible warrants completed in October 2024.

Fund Raising Details

The company successfully raised funds through convertible warrants with the following key parameters:

Fund Utilization Status

As of December 31, 2025, the company has utilized a portion of the raised funds according to the original allocation plan:

The funds were designated for multiple corporate purposes including capital expenditures, working capital requirements, acquisition activities, investment in technology, and general corporate purposes.

Regulatory Compliance

The disclosure confirms that there is no deviation or variation in the use of funds raised from their originally stated purposes. The company received in-principle approval on September 19, 2024, for issuing up to 916390 convertible warrants at ₹552 per warrant. The Board of Directors, in their meeting held on October 01, 2024, allotted 906390 convertible warrants upon receipt of subscription money totaling ₹12.51 crores.

Key Highlights

• No monitoring agency oversight required for this fund raising
• No comments from Audit Committee or auditors regarding fund utilization
• No deviation from original objects or allocation as disclosed to investors
• Funds being deployed as per the approved corporate purposes

The filing was signed by Company Secretary Hemaxi Pawar and submitted to both BSE Limited and National Stock Exchange of India Limited on February 12, 2026, maintaining transparency with stakeholders regarding fund deployment progress.

Diamines & Chemicals Limited announced its unaudited financial results for the quarter and nine months ended December 31, 2025, revealing a challenging operational environment with significant losses across both standalone and consolidated financials.

Financial Performance Overview

The company's financial performance showed marked deterioration compared to the previous year. On a consolidated basis, the company reported substantial losses while experiencing a significant decline in revenue from operations.

Quarterly Results Analysis

The third quarter results highlighted operational challenges with revenue declining significantly year-over-year. Total income on a consolidated basis fell to ₹816.60 crores from ₹1,828.47 crores in Q3FY25. Other income also decreased to ₹52.73 crores compared to ₹77.47 crores in the corresponding quarter last year.

Expenses remained elevated at ₹1,160.09 crores, resulting in a loss before tax of ₹343.49 crores compared to a profit before tax of ₹123.84 crores in Q3FY25. The company's earnings per share turned negative at ₹3.48 per share compared to a positive ₹0.77 per share in the previous year quarter.

Nine-Month Performance

The nine-month period ending December 31, 2025, reflected sustained operational difficulties. Consolidated revenue from operations declined to ₹2,919.20 crores from ₹5,353.83 crores in the corresponding nine-month period of the previous year.

Segment Performance

The company operates through two reportable segments: Speciality Chemicals and Trading in Fruits and Vegetables. The Speciality Chemicals segment generated the entire revenue of ₹763.87 crores in Q3FY26, while the Trading in Fruits and Vegetables segment remained inactive during the quarter. In Q3FY25, the Speciality Chemicals segment had contributed ₹1,705.91 crores while Trading in Fruits and Vegetables added ₹45.09 crores.

Segment results showed losses before tax and finance costs of ₹330.10 crores for Speciality Chemicals in Q3FY26 compared to a profit of ₹97.23 crores in Q3FY25.

Corporate Developments

The Board of Directors approved the unaudited financial results in their meeting held on February 12, 2026. The company also reviewed and approved its Related Party Policy under Regulation 23 of SEBI (LODR) (Fifth Amendment) Regulations, 2025. The trading window for directors and designated employees was closed from January 01, 2026, and reopened on February 15, 2026, in compliance with insider trading regulations.

The company made a provision of ₹4.62 lakhs due to the impact of new Labour Codes implemented by the Government of India effective from November 21, 2025. The results include the consolidated performance of Diamines and Chemicals Limited, its wholly-owned subsidiary DAACL Fine Chem Limited, and share of loss from associate KLJ Organic Diamines Limited.